References
- 1. FERLAY J., SOERJOMATARAM, I., ERVIK, M., DIKSHIT, R., ESER, S., MATHERS, C., et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Journal. 2013.
- 2. MCGLYNN K., TSAO, L., HSING, A., DEVESA, S. and FRAUMENI, J. International trends and patterns of primary liver cancer. Int J Cancer. 2001; 94:290-6.
- 3. SOMOVA A., GOLOSOVA, T., MARGOLINA, A. and BAGRIANTSEVA, S. The serodiagnosis of viral hepatitis C and B in different population groups. Voprosy Virusologii (Questions in Virology). 1992; 37:191-3.
- 4. KOSTRITSA S., KUZIN, S., KHUKHLOVICH, P., SHAKHGIL’DIAN, I., DOROSHENKO, N., BLINOV, V., et al. The detection of antibodies to the hepatitis C virus and to HBsAg in donors with viral hepatitis and cancerous diseases in the Republic of Moldova. Voprosy Virusologii (Questions in Virology). 1994; 39:93-4.
- 5. STEPANOV G., BONDARENKO, M. and LAROVOĬ, P. Role of the instrument transmission factor in the epidemiology of viral hepatitis. II. Methods, materials, chief results. Zh Mikrobiol Epidemiol Immunobiol. 1977; 4:133-9.
- 6. NEGRESKU G., IASHINA, T., BURKOV, A. and FAVOROV, M. The clinical picture and outcome of acute delta infection. Klin Med (Mosk). 1992; 70:80-4.
- 7. L’VOV D., MISHIRO, S., SELIVANOV, N., SAMOKHVALOV, E., SHAKHGIL’DIAN, I., STAKHANOVA, V., et al. Prevalence of genotypes of the hepatitis C virus, circulating in northwestern and central parts of Russia. Voprosy Virusologii (Questions in Virology). 1995; 40:251-3.
- 8. WORLD HEALTH ORGANIZATION. Global status report on alcohol and health 2014.
- 9. LACHENMEIER D., SCHOEBERL, K., KANTERES, F., KUBALLA, T., SOHNIUS, E., REHM, J., et al. Is contaminated unrecorded alcohol a health problem in the European Union? A review of existing and methodological outline for future studies. Addiction. 2011; 106:Suppl 1:20-30.
- 10. WHO W.H.O. Age-standardized death rates of liver cirrhosis. 2017.
- 11. TURCANU G., DOMENTE, S., BUGA, M. and RICHARDSON, E. Republic of Moldova health system review. 2012; 14.
- 12. TANASE A., MARCHIO, A., DUMITRASCU, T., DIMA, S., HERLEA, V., OPRISAN, G., et al. Mutation Spectrum of Hepatocellular Carcinoma from Eastern-European Patients betrays the Impact of a complex Exposome. J Exp Sci Env Epidemiol. 2014; 25:256-63.
- 13. SCHIAVON L., SCHIAVON, J., CARVALHO FILHO, R., SAMPAIO, J., LANZONI, V., SILVA, A., et al. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection. Hepatology. 2007; 46:307-14.
- 14. VALLET PICHARD A., MALLET, V., NALPAS, B., VERKARRE, V., NALPAS, A., DHALLUIN VENIER, V., et al. FIB 4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007; 46:32-6.
- 15. KINOSHITA A., ONODA, H., FUSHIYA, N., KOIKE, K., NISHINO, H. and TAJIRI, H. Staging systems for hepatocellular carcinoma: current status and future perspectives. World J Hepatol. 2015; 7:406.
- 16. JOHNSON P., BERHANE, S., KAGEBAYASHI, C., SATOMURA, S., TENG, M., REEVES, H., et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade. J Clin Oncol. 2014; 33:550-8.
- 17. DE MARTEL C., MAUCORT-BOULCH, D., PLUMMER, M. and FRANCESCHI, S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015; 62:1190-200.
- 18. RAZA S., CLIFFORD, G. and FRANCESCHI, S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer. 2007; 96:1127-34.
- 19. PERZ J., ARMSTRONG, G., FARRINGTON, L., HUTIN, Y. and BELL, B. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45:529-38.
- 20. SHAKHGIL’DIAN I., FARBER, N., KUZIN, S., CHESHIK, S., DROBENIUK, Z., MIKHAILOV, M., et al. Perinatal infection with hepatitis B virus and the problem of its specific prevention. Vestn Akad Med Nauk SSSR (Ann Russian Acad Med Sci). 1990; 7:29-32.
- 21. VOICULESCU M., ILIESCU, L., IONESCU, C., MICU, L., ISMAIL, G., ZILISTEANU, D., et al. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania. J Gastrointestin Liver Dis. 2010; 19:43-8.
- 22. BLACHIER M., LELEU, H., PECK-RADOSAVLJEVIC, M., VALLA, D. and ROUDOT-THORAVAL, F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol. 2013; 58:593-608.
- 23. GRIGORIE R., ALEXANDRESCU, S., SMIRA, G., IONESCU, M., HREHOREŢ, D., BRAŞOVEANU, V., et al. Curative Intent Treatment of Hepatocellular Carcinoma - 844 Cases Treated in a General Surgery and Liver Transplantation Center. Chirurgia (Bucur). 2017; 112:289-300.
- 24. HEIDRICH B., DETERDING, K., TILLMANN, H., RAUPACH, R., MANNS, M. and WEDEMEYER, H. Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat. 2009; 16:883-94.
- 25. WEDEMEYER H. and MANNS, M. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010; 7:31-40.
- 26. WRANKE A., PINHEIRO BORZACOV, L., PARANA, R., LOBATO, C., HAMID, S., CEAUSU, E., et al. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN). Liver Int. 2017; 38:842-50.
- 27. NEGRO F. Hepatitis D Virus Coinfection and Superinfection. Cold Spring Harb Perspect Med. 2014; 4:a021550.
- 28. TSATSRALT-OD B., TAKAHASHI, M., NISHIZAWA, T., ENDO, K., INOUE, J. and OKAMOTO, H. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. J Med Virol. 2005; 77:491-9.
- 29. DEGERTEKIN H., YALÇIN, K. and YAKUT, M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies. Turk J Gastroenterol. 2006; 17:25-34.
- 30. AMOUGOU ATSAMA M., NOAH NOAH, D., FEWOU MOUNDIPA, P., PINEAU, P. and NJOUOM, R. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa. BMC Infect Dis. 2016; 16:647.